Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 7 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

14%

1 trials in Phase 3/4

Results Transparency

50%

3 of 6 completed trials have results

Key Signals

3 with results

Enrollment Performance

Analytics

N/A

3(75.0%)

Phase 4

1(25.0%)

4Total

N/A(3)

Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials

NCT01062984Not ApplicableCompleted

Continuous Venovenous Hemofiltration Versus Continuous Venovenuous Hemodialysis

Role: collaborator

NCT03925454Completed

FREquent DIalysis & Markers of Cardiac Strain and Injury, Physical Fitness, Habitual Physical Activity & Quality of Life

Role: collaborator

NCT03633435Not ApplicableUnknown

Home Hemodialysis Assisted by a Nurse for Arterio-venous Fistula Cannulation

Role: collaborator

NCT02086682Completed

A Prospective Study of Airless Tubing in an Inpatient Acute Hemodialysis Unit in Hospitalized Patients

Role: collaborator

NCT00667511Not ApplicableCompleted

Comparison of Nocturnal Hemodialysis (NHD) and Short Daily Hemodialysis (DHD) With the NxStage® System One™

Role: lead

NCT00288613Completed

FREEDOM: Following Rehabilitation, Economics and Everyday-Dialysis Outcome Measurements Study

Role: lead

NCT00288587Phase 4Completed

Extracorporeal Ultrafiltration (UF) vs. Usual and Customary Care for Patients With Severe Heart Failure (HF)

Role: lead

All 7 trials loaded